Zhuhai United Laboratories Co., Ltd.
Clinical trials sponsored by Zhuhai United Laboratories Co., Ltd., explained in plain language.
A pharmaceutical company manufacturing and selling antibiotics and other medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new antibiotic tame tough urinary infections? a safety trial begins Results expected Dec 2026 (estimated)
- Could a new pill tame a rare blood disease? early safety trial begins Results expected May 2027 (estimated)
-
New insulin aspart put to the test: will it match the original?
Knowledge-focused CompletedThis study compares a new rapid-acting insulin (UBLIN®) to the approved NovoRapid® in 44 healthy men. Each participant receives a single dose of both insulins on separate days to see how the body absorbs and responds. The goal is to check if the new insulin works similarly, which…
Sponsor: Zhuhai United Laboratories Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New insulin vs. Brand-Name: a Head-to-Head test in healthy volunteers
Knowledge-focused CompletedThis trial tested how a new insulin injection (USLIN®R) compares to a standard brand (Novolin®R) in 32 healthy men. Each participant received both insulins at different times to measure how quickly and effectively they work. The goal is to see if the new insulin is similar enough…
Phase 1 • Sponsor: Zhuhai United Laboratories Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC